Stam Hanneke, van de Wiel Bart A, Klop W Martin C, Zupan-Kajcovski Biljana, Janssens Soe, Karakullukcu M Baris, van der Noort Vincent, Lohuis Peter J F M
Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Eur Arch Otorhinolaryngol. 2015 Apr;272(4):1001-1010. doi: 10.1007/s00405-014-3324-8. Epub 2014 Oct 16.
The objective of this study is to give more insight in the diagnosis, clinical course and therapy of skin adnexal carcinoma of the head and neck. Forty cases of skin adnexal carcinoma of the head and neck treated from 1977 to 2011 were identified by searching the hospitals cancer registration database. After pathology review by a pathologist specialized in skin cancer, 17 cases were excluded. A retrospective chart review of the remaining 23 patients was performed. Clinical course was recorded by endpoints including survival, loco-regional control and recurrence free survival. Prognostic factors considered for analysis were differentiation of the tumor and location of the tumor. Five-year overall survival (OS) was 78 % (95 % CI 61-100 %). Five-year recurrence free survival (RFS) was 58 % (95 % CI 40-84 %). Poor differentiation of the tumor significantly reduced OS (p = 0.002) and RFS (p = 0.01). Tumor location 'face' demonstrated a significantly better survival than other tumor locations (p < 0.001). Local recurrence occurred in five cases, regional metastasis was seen in seven patients, distant metastasis in three patients. Three cases with distant metastases died of disease. Based on the findings of this small group of patients in a tertiary referral center, we conclude that skin adnexal carcinoma is a very rare skin carcinoma that can behave locally aggressive but also has the potential for regional and distant metastasis. The recognition of skin adnexal carcinoma and subsequent wide excision in an early stage of the disease is of major importance for loco-regional control and survival.
本研究的目的是更深入地了解头颈部皮肤附属器癌的诊断、临床病程及治疗。通过检索医院癌症登记数据库,确定了1977年至2011年期间治疗的40例头颈部皮肤附属器癌患者。经皮肤癌专科病理学家进行病理复查后,排除了17例。对其余23例患者进行了回顾性病历审查。临床病程通过生存、局部区域控制和无复发生存等终点指标进行记录。分析时考虑的预后因素为肿瘤的分化程度和肿瘤的位置。五年总生存率(OS)为78%(95%可信区间61-100%)。五年无复发生存率(RFS)为58%(95%可信区间40-84%)。肿瘤低分化显著降低了总生存率(p = 0.002)和无复发生存率(p = 0.01)。肿瘤位于“面部”的患者生存率明显高于其他肿瘤部位(p < 0.001)。5例出现局部复发,7例出现区域转移,3例出现远处转移。3例发生远处转移的患者死于该疾病。基于在三级转诊中心这一小群患者的研究结果,我们得出结论,皮肤附属器癌是一种非常罕见的皮肤癌,其行为可能具有局部侵袭性,但也有发生区域和远处转移的可能。识别皮肤附属器癌并在疾病早期进行广泛切除对于局部区域控制和生存至关重要。